SVRA – savara, inc. (US:NASDAQ)
Stock Stats
News
12/2
02:41 pm
svra
Low
Savara Inc. ticks higher amid takeover speculation [Seeking Alpha]
12/2
08:05 am
svra
Low
Savara and PARI Granted a European Patent Covering the Drug-Device Combination of MOLBREEVI* Delivered Via the Proprietary eFlow® Nebulizer System
11/20
04:05 pm
svra
Medium
Savara Announces Participation in Upcoming Investor Healthcare Conferences
11/16
06:36 am
svra
Low
Savara: A High-Risk Opportunity [Seeking Alpha]
11/14
12:31 pm
svra
Low
Savara (NASDAQ:SVRA) had its price target raised by analysts at Oppenheimer Holdings, Inc. from $8.00 to $9.00. They now have an "outperform" rating on the stock.
11/12/2025
04:05 pm
SVRA
1.0%
MISS
8/13/2025
08:05 am
SVRA
4.7%
MISS
5/13/2025
04:05 pm
SVRA
0.7%
IN-LINE
3/27/2025
07:05 am
SVRA
4.9%
MISS
11/14
12:28 pm
Maintains
Outperform
Outperform
Oppenheimer
Low
-0.7%
11/14
12:28 pm
Maintains
Outperform
Outperform
Oppenheimer
Low
-0.7%
10/23
09:08 am
Reiterates
Outperform
Outperform
Citigroup Inc.
Low
-1.0%
10/23
07:24 am
Maintains
Market Outperform
Market Outperform
JMP Securities
Low
-1.0%
10/23
07:24 am
Maintains
Market Outperform
Market Outperform
JMP Securities
Low
-1.0%
12/4
06:57 pm
svra
Low
Form 4 Savara Inc For: Dec 04 Filed by: Wasfi Yasmine
12/4
06:55 pm
svra
Low
Form 4 Savara Inc For: Dec 02 Filed by: Elam Nevan C
11/17
04:38 pm
svra
Low
Form 4 Savara Inc For: Nov 14 Filed by: Hawkins Richard J
11/14
05:37 pm
svra
Low
Form SCHEDULE 13G/A Savara Inc Filed by: Venrock Healthcare Capital Partners III, L.P.
11/14
04:43 pm
svra
Low
Form SCHEDULE 13G Savara Inc Filed by: Nantahala Capital Management, LLC
Show more
Top News Gainers
12/30 Savara Granted Breakthrough Therapy Designation for Molgradex for the Treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP) 180.6%
11/15 Form 8-K Savara Inc For: Nov 15 21.1%
11/27 Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 18.9%
12/20 Form 8-K Savara Inc For: Dec 20 15.1%
6/28 Form 4 Savara Inc For: Jun 26 Filed by: RAMSAY DAVID A 13.9%
12/20 Savara Announces Private Placement of $26.8 Million, With Total Potential Proceeds of $75.0 Million 10.4%
3/25 Statement Of Support By The PAP Foundation, Inc. For FDA Approval Of GM-CSF Treatment For aPAP 8.2%
10/31 Savara to Report Third Quarter 2019 Financial Results and Provide Business Update 7.3%
3/17 Savara Inc (NASDAQ: SVRA) had its "buy" rating re-affirmed by analysts at HC Wainwright. 6.3%
4/9 Form SC 13G/A Savara Inc Filed by: BlackRock Inc. 6.1%
Top News Decliners
10/2 Savara Announces FDA Response From Type C Meeting on Molgradex for aPAP Development Program -58.5%
3/17 Form 4 Savara Inc For: Mar 10 Filed by: Sun Ricky -19.4%
2/3 Form 8-K Savara Inc For: Jan 31 -15.8%
4/2 Form 8-K Savara Inc For: Mar 31 -14.3%
12/30 Form SC 13D Savara Inc Filed by: Bain Capital Life Sciences Fund II, L.P. -12.8%
3/12 Q4/2019 12/31/2019 EPS -0.720 ZacksConsensus -0.310 ActVsEst (0.410) - Miss -9.8%
3/30 Savara Provides Business Update in Response to COVID-19 Pandemic -9.8%
12/3 Savara Announces the Appointment of Dr. An van Es-Johansson to Board of Directors -8.4%
8/8 Q2/2019 6/30/2019 EPS -0.570 ZacksConsensus -0.430 ActVsEst (0.140) - Miss -8.4%
6/13 Savara Inc (NASDAQ: SVRA) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -8.2%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3